Skip to main content

Systemischer Lupus erythematodes

  • Chapter

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • ACR clinical guidelines committee (1996) Arthritis Rheum 39: 723–731

    Google Scholar 

  • Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR (1992) Outcome of treated pregnancies in women with anti-phospholipid syndrome: an update of the Utah experience. Obstet Gynecol 80: 614–620

    CAS  PubMed  Google Scholar 

  • Burt RK, Marmont A, Schroeder J, Rosa R, Traynor AE (2000) Intense immune suppression for systemic lupus — the role of hematopoietic stem cells. J Clin Immunol 20: 31–37

    CAS  PubMed  Google Scholar 

  • Chan TM, Li FK, Tang CS et al. (Hong Kong-Guangzhou Nephrology Study Group) (2000) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N Engl J Med 343: 1156–1162

    Article  CAS  PubMed  Google Scholar 

  • Contreras G, Pardo V, Leclerq B et al. (2004) Sequential therapies for proliferative lupus nephritis. N Engl J Med 350: 971–980

    Article  CAS  PubMed  Google Scholar 

  • Crowther MA, Ginsberg JS, Julian J et al. (2003) A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome. N Engl J Med 349: 1133–1138

    Article  CAS  PubMed  Google Scholar 

  • Diehm C, Heidrich H, Sprengel F, Schulte KL, Theis W (2000) Die medikamentöse Therapie der arteriellen Verschlusskrankheit. Internist 41: 1416–1422

    Article  CAS  PubMed  Google Scholar 

  • Hallegua D, Wallace DJ, Metzger AL, Rinaldi RZ, Klinenberg JR (2000) Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature. Lupus 9: 241–251

    CAS  PubMed  Google Scholar 

  • Klippel JH, Weyand CM, Wortmann RL (eds) (1997) Primer of the rheumatic diseases, 11th edn. Arthritis Foundation, Georgia

    Google Scholar 

  • Lorenz HM, Herrmann M, Winkler T, Gaipl U, Geiler T, Kalden JR (2000) A role for apoptosis in autoimmunity. Apoptosis 5: 441–447

    Article  Google Scholar 

  • Mojcik CF, Klippel JH (1996) End stage renal disease and systemic lupus erythematosus. Am J Med 101: 100–107

    Article  CAS  PubMed  Google Scholar 

  • Ostensen M, Ramsey-Goldman R (1998) Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options? Drug Saf 19: 389–410

    CAS  PubMed  Google Scholar 

  • Spinatto JA, Clark AL, Pierangeli SS, Harris EN (1995) Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy. Am J Obstet Gynecol 172: 690–694

    Google Scholar 

  • Wilder RL (1997) Corticosteroids. In: Klippel JH, Weyand CM, Wortmann RL (eds) Primer of the rheumatic diseases. Arthritis Foundation, Atlanta

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Heidelberg

About this chapter

Cite this chapter

Lorenz, HM. (2005). Systemischer Lupus erythematodes. In: Schölmerich, J., et al. Medizinische Therapie 2005|2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27385-9_12

Download citation

  • DOI: https://doi.org/10.1007/3-540-27385-9_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21226-3

  • Online ISBN: 978-3-540-27385-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics